Keeping Track: Clovis Completes NDA; FDA Clears 3D-Printed Antiepileptic But Declines Preservative-Free Eye Drug
Executive Summary
The latest drug development news and highlights from our FDA Performance Tracker.
You may also be interested in...
US FDA Progress Report Highlights Biomarkers, Continuous Manufacturing, Antibiotic Testing
Agency documents its regulatory science accomplishments to advance product development and manufacturing and ensure the safety and effectiveness of marketed products.
Change Is Constant For Pneumococcal Vaccines: US CDC Prepares For Merck’s V116
As Merck’s 21-valent vaccine approaches its 17 June user fee goal, the US CDC’s vaccine committee is looking at new adult age-based recommendations and bracing for a full pipeline led by GSK’s 24-valent candidate.
US FDA Expects Joint AdComm Briefing Document, Oncology Chief Says
The combined format is the new default for briefing advisory committee members, US FDA Oncology Center of Excellence Director Pazdur declared.